LifePoint Hospitals, Inc. (LPNT) - NASDAQ
  • Thu, May 12, 4:20 PM
    • Hospital stocks took it on the chin today as bearish investors anticipate the potential softening of revenues after a federal judge ruled that the Obama administration is unconstitutionally spending money to reimburse health insurers for the extra cost of providing coverage to low-income Americans under the Affordable Care Act (ACA) without obtaining an appropriation from Congress.
    • House Republicans sued Obama accusing the President of violating the law by delaying the enforcement of several provisions of the ACA. Lawyers later focused on the reimbursements, which could be as high as $175B over a decade according to Republicans. Predictably, administration attorneys say the suit should be dismissed because the House has no legal right to sue considering the reimbursements were authorized by law.
    • Judge Rosemary Collyer, appointed by George W. Bush in 2002, issued an order stopping further reimbursements, but its implementation will be delayed until the appeal process runs its course.
    • Related tickers: (CYH -10.8%)(HUM -2.5%)(HCA -3.2%)(HLS -1.5%)(KND -8.1%)(LPNT -3.3%)(THC -9.8%)(SSY -1.5%)
    | Thu, May 12, 4:20 PM | 6 Comments
  • Thu, May 12, 9:22 AM
    • LifePoint Health (NASDAQ:LPNT) will proceed with a private offering of $400M aggregate principal amount of Senior Notes due 2024. Price and terms have yet to be announced. Net proceeds, along with cash on hand, will fund the redemption of its $400M 6.625% Senior Notes due 2020.
    • When the company prices the offering, it will issue a conditional notice of redemption to redeem all of the outstanding 6.625% Senior Notes on June 13.
    | Thu, May 12, 9:22 AM
  • Fri, Apr. 29, 10:32 AM
    • LifePoint Hospitals (LPNT -6.8%) Q1 results: Revenues: $1,580.7M (+25.1%); Salaries and benefits: $765.7M (+25.3%); Supplies: $262.4M (+33.3%); Other operating expenses: $397.3M (+35.3%); Net Income: $21.6M (-44.5%); EPS: $0.48 (-42.9%); Non-GAAP EPS: $0.87 (-13.0%); Quick Assets: $187M (-34.2%); CF Ops: $88.7M (-50.6%).
    • No guidance given.
    | Fri, Apr. 29, 10:32 AM
  • Fri, Apr. 29, 7:01 AM
    • LifePoint Hospitals (NASDAQ:LPNT): Q1 EPS of $0.87 misses by $0.01.
    • Revenue of $1.58B (+25.4% Y/Y) beats by $10M.
    • Press Release
    | Fri, Apr. 29, 7:01 AM
  • Thu, Apr. 28, 5:30 PM
    | Thu, Apr. 28, 5:30 PM | 3 Comments
  • Fri, Feb. 12, 7:42 AM
    • LifePoint Hospitals (LPNT -5.1%) Q4 results: Revenues: $1,370.7M (+8.5%); Salaries and benefits: $652.7M (+6.6%); Supplies: $218.4M (+9.7%); Other Operating Expense: $330.9M (+10.3%); Net Income: $53M (+136.6%); EPS: $1.16 (+141.7%); Non-GAAP EPS: $1.11 (+2.8%).
    • FY2015 results: Revenues: $5,214.3M (+16.3%); Salaries and benefits: $2,496.9M (+17.0%); Supplies: $815M (+16.6%); Other Operating Expense: $1,246.4M (+14.6%); Net Income: $181.9M (+44.3%); EPS: $3.95 (+46.8%); Non-GAAP EPS: $4.09 (+18.6%); Quick Assets: $284M (+48.3%).
    • 2016 Guidance: Net Revenue: $6.45B - 6.55B; Adjusted EBITDA: $765M - 795M; EPS: $3.65 - 3.91.
    | Fri, Feb. 12, 7:42 AM
  • Fri, Feb. 12, 7:01 AM
    • LifePoint Hospitals (NASDAQ:LPNT): Q4 EPS of $1.11 beats by $0.05.
    • Revenue of $1.37B (+8.7% Y/Y) in-line.
    • Press Release
    | Fri, Feb. 12, 7:01 AM
  • Thu, Feb. 11, 5:30 PM
    | Thu, Feb. 11, 5:30 PM | 1 Comment
  • Fri, Jan. 22, 8:38 AM
    • Zafgen's (NASDAQ:ZFGN) recent bullish action gets some attention: FBR & Co. upgrades to Outperform from Market Perform. Price target raised to $20 (120% upside) from $9; RBC Capital upgrades to Outperform from Sector Perform. Price target raised to $21 (131% upside).
    • Anthem (NYSE:ANTM) upgraded to Buy from Neutral by Goldman Sachs. Price target raised to 168 (21% upside) from $160.
    • Kite Pharma (NASDAQ:KITE) upgraded to Outperform from Market Perform by FBR & Co. Price target raised to $75 (47% upside) from $72.
    • AstraZeneca (NYSE:AZN) upgraded to Equal Weight from Underweight by Barclays. Price target raised to ₤50 from ₤44.
    • LifePoint Health (NASDAQ:LPNT) downgraded to Neutral from Buy by Goldman Sachs. Price target lowered to $78 (17% upside) from $81.
    | Fri, Jan. 22, 8:38 AM
  • Dec. 18, 2015, 12:18 PM
    • Biogen (BIIB +0.2%) initiated with Overweight rating and $344 (16% upside) price target by Atlantic Equities.
    • CVS Health (CVS -0.1%) initiated with Overweight rating and $110 (16% upside) price target by Barclays.
    • Clovis Oncology (CLVS +0.9%) initiated with Buy rating and $50 (48% upside) price target by Janney.
    • Relypsa (RLYP +2.6%) initiated with Buy rating and $63 (123% upside) price target by H.C. Wainwright.
    • HCA Holdings (HCA -0.2%) initiated with Outperform rating and $75 (16% upside) price target; LifePoint Health (LPNT +0.4%) with an Outperform rating and $79 (13% upside) price target; Tenet Healthcare (THC +1.2%) with a Neutral rating and $33 (18% upside) price target and Universal Health Services (UHS +0.4%) with a Neutral rating and $129 (11% upside) price target by Credit Suisse.
    • Amgen (AMGN -0.1%) upgraded to Overweight from Equal Weight by Morgan Stanley. Price target raised to $193 (20% upside) from $160.
    • Valeant Pharmaceuticals (VRX -1.8%) downgraded to Neutral from Buy by Mizuho Securities. Price target raised to $130 (19% upside) from $111.
    | Dec. 18, 2015, 12:18 PM
  • Oct. 30, 2015, 10:52 AM
    • LifePoint Hospitals (LPNT +1.3%) Q3 results: Revenues: $1,309.5M (+12.3%); Salaries and Benefits: $626.2M (+12.1%); Supplies: $205.7M (+14.0%); Other Operating Expense: $313.2M (+9.7%); Net Income: $43.6M (+58.5%); EPS: $0.94 (+59.3%); Quick Assets: $313.2M (+63.6%).
    • No guidance given.
    | Oct. 30, 2015, 10:52 AM
  • Oct. 30, 2015, 7:07 AM
    • LifePoint Hospitals (NASDAQ:LPNT): Q3 EPS of $0.94 may not be comparable to consensus of $0.90.
    • Revenue of $1.31B (+12.0% Y/Y) beats by $10M.
    | Oct. 30, 2015, 7:07 AM
  • Oct. 29, 2015, 5:30 PM
    | Oct. 29, 2015, 5:30 PM | 19 Comments
  • Jul. 31, 2015, 10:09 AM
    • LifePoint Hospitals (LPNT -3.9%) Q2 results: Revenues: $1,270.4M (+21.3%); Salaries and benefits: $606.8M (+24.2%); Supplies: $194.1M (+19.4%); Other operating expenses: $308.7M (+19.5%); Net Income: $46.4M (+18.7%); EPS: $1.00 (+19.0%); Quick Assets: $422.8M (+120.8%).
    • 2015 Guidance: Net Revenue: $5.15B - 5.25B; Adjusted EBITDA: $695M - 720M; Adjusted EPS: $3.75 - 4.06.
    | Jul. 31, 2015, 10:09 AM
  • Jul. 31, 2015, 7:03 AM
    • LifePoint Hospitals (NASDAQ:LPNT): Q2 EPS of $1.00 beats by $0.01.
    • Revenue of $1.27B (+21.0% Y/Y) beats by $30M.
    | Jul. 31, 2015, 7:03 AM
  • Jul. 30, 2015, 5:30 PM
    | Jul. 30, 2015, 5:30 PM | 4 Comments
Company Description
LifePoint Health, Inc. operates general acute care hospitals in non-urban communities in U.S. The company provides medical and surgical services commonly available in hospitals in non-urban markets, including general surgery, internal medicine, obstetrics, emergency room care, radiology,... More
Sector: Healthcare
Industry: Hospitals
Country: United States